NCT00578149View on ClinicalTrials.gov

Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Bevacizumab

DRUG

Carboplatin

DRUG

Paclitaxel

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00578149 - Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter